Unternehmen
CONSORTIUM FOR GENOMIC TECHNOLOGIESSOCIETA BENEFIT SRL
CONSORTIUM FOR GENOMIC TECHNOLOGIESSOCIETA BENEFIT SRL – Unternehmen mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Projekt
→
GENOMIC SURVEILLANCE TO CONTROL PATHOGEN INFECTIONS IN AFRICA
The overall goal of GenPath Africa is to control pathogen infections in Africa. Our consortium of African and European investigat… Beitrag ansehen →
Projekt
→
Accelerating datafication for support of EU health priorities, greening of biobanks and integrated approach to “One Health”
Since its creation, the Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consorti… Beitrag ansehen →
Projekt
→
MAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFIT
Advanced Therapy Medicinal Products (ATMPs) are medicines based on genes, cells and tissues for human use. They can provide patie… Beitrag ansehen →
Unternehmen
→
MIXCYCLING SRL SOCIETA BENEFIT
MIXCYCLING SRL SOCIETA BENEFIT – Unternehmen mit Aktivitäten in Forschung und Innovation. Beitrag ansehen →
Unternehmen
→
PLUSVALUE ITALY SRL SOCIETA BENEFIT
PLUSVALUE ITALY SRL SOCIETA BENEFIT – Unternehmen mit Aktivitäten in Forschung und Innovation. Beitrag ansehen →
Unternehmen
→
EULERIA SRL SOCIETA BENEFIT
EULERIA SRL SOCIETA BENEFIT – Unternehmen mit Aktivitäten in Forschung und Innovation. Beitrag ansehen →
Passend zu diesem Beitrag
Forschungsprojekte
- Comprehensive STRategIes to tacKlE malignant tumors: from nanomedicine and theranostics to precision medicine STRIKE-DN will raise excellence in research and training in nanomedicine/precision medicine creating new gene… →
- A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL SAGITTARIUS aim to optimize the clinical management of locoregional stage II high-risk/stage III colon cancer… →